Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Deciphering the chemical language of the immunomodulatory properties of Veillonella parvula lipopolysaccharide

  • Pither, Molly D.
  • Andretta, Emanuela
  • Rocca, Giuseppe
  • Balzarini, Fabio
  • Matamoros-Recio, Alejandra
  • Colicchio, Roberta
  • Salvatore, Paola
  • Van Kooyk, Yvette
  • Silipo, A.
  • Granucci, Francesca
  • Martín-Santamaría, Sonsoles
  • Chiodo, Fabrizio
  • Di Lorenzo, Flaviana
14 p.-5 fig.-1 schem., Veillonella parvula, prototypical member of the oral and gut microbiota, is at times commensal yet also potentially pathogenic. The definition of the molecular basis tailoring this contrasting behavior is key for broadening our understanding of the microbiota driven pathogenic and/or tolerogenic mechanisms that take place within our body. In this study, we focused on the chemistry of the main constituent of the outer membrane of V. parvula, the lipopolysaccharide (LPS). LPS molecules indeed elicit pro-inflammatory and immunomodulatory responses depending on their chemical structures. Here we report about the structural elucidation of the LPS from two strains of V. parvula and show important and unprecedented differences in both the lipid and carbohydrate moieties, including the identification of a novel galactofuranose and mannitol-containing O-antigen repeating unit for one of the two strains. Furthermore, by harnessing computational studies, in vitro human cell models, as well as lectin binding solid phase assays, we discovered that the two chemically diverse LPS immunologically behave differently and have attempted to identify the molecular determinant(s) governing this phenomenon. Whether a pro-inflammatory potential has been evidenced for the lipid A moiety, by contrast a plausible “immune modulating” action has been proposed for the peculiar O-antigen portion., This study was supported by the European Research Council (ERC) under the Horizon Europe program under grant agreement No 101039841 (DEBUGGING LPS) and by the project "CLariFY" funded by the MUR Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN) Bando 2022 -grant 2022SHW3KY to F.D.L. and F.C. This work was also supported in part by the Italian Ministry of Foreign Affairs and International Cooperation(Italy-Germany Science and Technology cooperation–Call for joint research proposals for the years 2023-2025). It also benefited ofthe projects “GiVIng” funded by Prin PNRR 2022 to F.C.and F.D.L.(grant P202293ZMC),and H2020-MSCA-ITN-2020 grant agreement 956758 (GLYTUNES) to A.S., F.B., Y.v.K., and F.C., and by the Spanish Ministry for Science and Innovation (grantPID2020-113588RB-I00) to S.M.S. and (grant PRE2018-086249) A.M.R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structure of the Lipopolysaccharide from : A Chemical Perspective on Immune Recognition

  • Nieto-Fabregat, Ferran
  • Mercogliano, Marcello
  • Cangiano, Alessandro
  • Vitiello, Giuseppe
  • Andretta, Emanuela
  • Clifton, Luke A.
  • Vanacore, Adele
  • Buono, Lorena
  • Campanero-Rhodes, María Asunción
  • Solís, Dolores
  • Di Carluccio, Cristina
  • Pecoraro, Giovanni
  • Molinaro, Antonio
  • Smaldone, Giovanni
  • Kim, Jeon-Kyung
  • Kim, Dong-Hyun
  • Paduano, Luigi
  • Di Lorenzo, Flaviana
  • Silipo, Alba
17 pages, 9 figures, Gram-negative bacterium , which is increasingly prevalent in elderly individuals, is associated with cognitive decline and gut-brain axis dysfunction. Here, we present a comprehensive structural characterization of lipopolysaccharide (LPS), a key modulator of immune recognition and the main component of its outer membrane. Using a multidisciplinary approach combining chemical, spectroscopic, spectrometric, biophysical and computational methods, we unveil a unique O-antigen characterized by a trisaccharide repeating unit containing rhamnose and glucosamine, displaying nonstoichiometric O-acetylation and a terminal methylated rhamnose capping the saccharide chain. Furthermore, we disclose a short core oligosaccharide and a Lipid A composed of penta- to tetra-acylated species. Notably, this LPS exhibits reduced activation of Toll-Like Receptor-dependent signaling compared to the highly immunostimulatory LPS and elicits a poor pro-inflammatory cytokine response. Moreover, LPS exhibits selective binding to immune lectins such as Ficolin-3 and Galectin-4, as shown by the microarray assays. This raises the possibility that lectin-mediated recognition may represent an alternative route of immune engagement, which could help explain altered immune responses observed in elderly individuals. These findings provide a molecular basis for further exploring the role of LPS in microbiota-induced immune modulation and its possible impact on age-related inflammatory and neurodegenerative conditions., A.S. acknowledges Ministry of Education, Universities and Research, PRIN MUR 2022 (2022ZEZS45) and PRIN MUR PNRR 2022 (P2022M457Z). F.N.-F. acknowledges support from the Italian MUR, PRIN 2020, Project SEA-WAVE 2020BKK3W9, and from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 851356). European Union (FSE, PON Ricerca e Innovazione 2014−2020, Azione I.1 “Dottorati Innovativi con caratterizzazione Industriale”) for funding the Ph.D. grant to A.V. and A.S. acknowledge PNRR, Missione 4 Componente 2 Next GenerationEU Partenariato Esteso INF-ACT One Health Basic and Translational Research Actions Addressing Unmet Needs on Emerging Infectious Diseases MUR: PE00000007. F.D.L. acknowledges European Research Council (ERC) under the Horizon Europe program under grant agreement No 101039841 (DEBUGGING LPS). This work was also supported in part by the Italian Ministry of Foreign Affairs and International Cooperation (Italy-Germany Science and Technology cooperation−Call for joint research proposals for the years 2023−2025) to F.D.L. F.D.L. also acknowledges Ministry of Universities and Research, PRIN MUR 2022 (2022SHW3KY) and PRIN MUR PNRR 2022 (P202293ZMC). MAC-R and DS were funded by grant PID2022-143249OB-I00 of MCIN/AEI/10.13039/ 501100011033 and “ERDF A way of making Europe”, and by CIBER (Consorcio Centro de Investigación Biomédica en Red (CIBERES), Instituto de Salud Carlos III), CB06/06/0037. The authors gratefully acknowledge the financial support of Consiglio Nazionale delle Ricerche within CNR-STFC Agreement 2021-2027 (N 0065606), concerning collaboration in scientific research RB2210267 at the ISIS Neutron and Muon Source (UK) of Science and Technology Facilities Council (STFC). This manuscript is partially supported by Italian ministry of Health by the “Ricerca Corrente” projects. This research was also funded under the National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3 Call for tender No. 341 of 15 March 2022 of Italian Ministry of University and Research funded by the European Union NextGenerationEU. Project code PE00000003, Concession Decree No. 1550 of 11 October 2022, adopted by the Italian Ministry of University and Research, CUP E63C22002030007, Project title “ON Foods Research and innovation network on food and nutrition Sustainability, Safety and Security Working ON Foods, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Odoribacter splanchnicus lipooligosaccharide: an uncommon structure with weak immunostimulatory activity

  • Tiemblo-Martín, Marta
  • Mercogliano, Marcello
  • Hiippala, Kaisa
  • De Simone Carone, Luca
  • Campanero-Rhodes, María Asunción
  • Masiello, Maria
  • Cangiano, Alessandro
  • Molinaro, Antonio
  • Paduano, Luigi
  • Solís, Dolores
  • Satokari, Reetta
  • Di Lorenzo, Flaviana
  • Silipo, Alba
[Data statement] The data supporting this article have been included as part of the supplementary information (SI). Supplementary information: SI reports Fig. S1–S3 with SDS-PAGE, NMR and MS data, as well as Tables S1–S3 with NMR and microarray data. See DOI: https://doi.org/10.1039/d5sc08335d., Odoribacter splanchnicus, a prominent member of the human gut microbiota, has emerged as a promising next-generation probiotic due to its anti-inflammatory properties and association with intestinal health. While previous studies have demonstrated its ability to attenuate inflammation and protect epithelial integrity, the molecular basis underlying these effects remained elusive. In this study, we provide the first comprehensive structural and functional characterization of the O. splanchnicus lipooligosaccharide (LOS), a major immunomodulatory surface component. NMR spectroscopy and mass spectrometry revealed a heterogeneous LOS structure composed of a mono-phosphorylated tetra- and penta-acylated lipid A backbone and a highly branched, short core oligosaccharide featuring unique residues such as 4-lactylmannose and galactosaminuronic acid. Small-angle X-ray scattering demonstrated that the LOS self-assembles into core-shell spherical micelles, with a large oligosaccharide corona shielding the lipid A, thereby limiting its accessibility to the innate immunity TLR4/MD-2 receptor complex. Accordingly, the O. splanchnicus LOS exhibited minimal TLR4 activation and failed to induce IL-8 secretion in enterocyte cell lines, in stark contrast to proinflammatory Escherichia coli LPS; in addition, it potently antagonized E. coli LPS-induced inflammation. These findings identify the LOS as a key effector of the O. splanchnicus anti-inflammatory phenotype and support its further development as a live biotherapeutic agent., The authors wish to thank the Diamond Light Source for providing beamtime (reference SM34244-1). This work was supported by the European Research Council (ERC) under the Horizon Europe program under grant agreement no. 101039841 (DEBUGGING LPS) to F. D. L. This work has also received funding from the European Union's Horizon Europe research and innovation programme under grant agreement no. 101095084 for the ENDOTARGET project, which is also supported by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 22.00462. It was also supported by the project "CLariFY" and "GIVING" funded by the Italian Ministry of University and Research, PRIN MUR 2022 (2022SHW3KY) and PRIN MUR PNRR 2022 (P202293ZMC) to F. D. L. MAC-R and DS were funded by grant PID2022-143249OB-I00 of MCIN/AEI/10.13039/501100011033 and "ERDF A way of making Europe", and by CIBER (Consorcio Centro de Investigación Biomédica en Red (CIBERES), Instituto de Salud Carlos III), CB06/06/0037. This work was also supported in part by the Italian Ministry of Foreign Affairs and International Cooperation (Italy Germany Science and Technology cooperation–Call for joint research proposals for the years 2023–2025). This research was funded under the National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3—Call for tender no. 341 of 15 March 2022 of Italian Ministry of University and Research funded by the European Union—NextGenerationEU. Project code PE00000003, Concession Decree no. 1550 of 11 October 2022, adopted by the Italian Ministry of University and Research, CUP E63C22002030007, Project title "ON Foods—Research and innovation network on food and nutrition Sustainability, Safety and Security—Working ON Foods". H2020-MSCA-ITN-2020, contract no. 956758 (AS, MTM). Ministry of Education, Universities and Research, PRIN MUR 2022 (2022ZEZS45) and Ministry of Education, Universities and Research, PRIN MUR PNRR 2022 (P2022M457Z) (AS). PNRR, Missione 4 – Componente 2 – NextGenerationEU – Partenariato Esteso INF-ACT – One Health Basic and Translational Research Actions Addressing Unmet Needs on Emerging Infectious Diseases MUR: PE00000007 (AS)., Peer reviewed